
Faron Pharmaceuticals has seen its share price plummet by more than 80% after it emerged that its recombinant human interferon …
Brenntag and dsm-firmenich expand biopharma vitamin partnership
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership

